Research suggests that EGCG, the primary catechin found in high concentrations in matcha, may have antioxidant-related properties that extend to interfering with oxidative and molecular processes at the cellular level, including, in one laboratory study, blocking viral entry mechanisms linked to SARS-CoV-2. The available evidence here consists of a single cell-based laboratory study, which is a preliminary type of research that does not involve human participants, meaning its findings cannot be directly applied to how matcha or EGCG would behave in the human body. Studies indicate that while the antioxidant activity of EGCG showed promising results in this controlled setting, the authors themselves acknowledged that cell-based outcomes do not automatically translate to real-world effectiveness. Readers should keep in mind that one in vitro study represents a very early stage of evidence, and broader conclusions about matcha's antioxidant support in humans would require clinical trials to substantiate.
Citations from PubMed and preprint sources. Match score (0-100) reflects automated search ranking, not clinical appraisal.
| Title | Type | Year | Direction | Match |
|---|---|---|---|---|
| Epigallocatechin Gallate from Green Tea Effectively Blocks Infection of SARS-... | Other | 2021 | Neutral | 85 |